North America Automated Compounding Devices Market - 2024-2031
North America Automated Compounding Devices Market reached US$ 362.27 million in 2023 and is expected to reach US$ 529.17 million by 2031, growing with a CAGR of 5.00% during the forecast period 2026-2031.
The North America Automated Compounding Devices Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A North America Automated Compounding Devices Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Product Type
Both primary and secondary data sources have been used in the global North America Automated Compounding Devices Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
The North America Automated Compounding Devices Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A North America Automated Compounding Devices Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Product Type
- Intravenous (IV) Compounding Systems *
- Oral Liquid Compounding Systems
- TPN (Total Parenteral Nutrition) Compounding Systems
- Chemotherapy Compounding Systems
- Gravimetric Automated Compounding Devices *
- Volumetric Automated Compounding Devices
- Syringe-based Automated Compounding Devices
- Hardware *
- Software
- Services
- Fully Automated Compounding Devices*
- Semi-Automated Compounding Devices
- Hospitals*
- Ambulatory Surgical Centers
- Others
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global North America Automated Compounding Devices Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by Component
3.4. Snippet by Mode of Operation
3.5. Snippet by End-User
3.6. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Technological Advancements in Automated Compounding Devices
4.1.1.2. The Prevalence of Cancer
4.2. Restraints
4.2.1. The High Cost of ACD Systems
4.2.2. Opportunity
4.2.3. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 ANALYSIS
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY PRODUCT TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Intravenous (IV) Compounding Systems *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Oral Liquid Compounding Systems
7.4. TPN (Total Parenteral Nutrition) Compounding Systems
7.5. Chemotherapy Compounding Systems
8. BY TECHNOLOGY
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.1.2. Market Attractiveness Index, By Technology
8.2. Gravimetric Automated Compounding Devices *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Volumetric Automated Compounding Devices
8.4. Syringe-based Automated Compounding Devices
9. BY COMPONENT
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.1.2. Market Attractiveness Index, By Component
9.2. Hardware *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Software
9.4. Services
10. BY MODE OF OPERATION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Operation
10.1.2. Market Attractiveness Index, By Mode of Operation
10.2. Fully Automated Compounding Devices*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Semi-Automated Compounding Devices
11. BY END-USER
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.1.2. Market Attractiveness Index, By End-User
11.2. Hospitals*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Ambulatory Surgical Centers
11.4. Others
12. BY COUNTRY
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.1.2. Market Attractiveness Index, By Country
12.2. North America
12.2.1. U.S.
12.2.2. Canada
12.2.3. Mexico
13. COMPETITIVE LANDSCAPE
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. COMPANY PROFILES
14.1. Grifols, S.A *
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Baxter International Inc
14.3. COMECER S.p.A.
14.4. ARxIUM
14.5. ICU Medical, Inc
14.6. Omnicell, Inc
14.7. EQUASHIELD
14.8. B. Braun Medical Inc
14.9. BECTON, DICKINSON AND COMPANY
14.10. SMARTCOMPOUNDERS B.V. (*LIST NOT EXHAUSTIVE)
15. APPENDIX
15.1. About Us and Services
15.2. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by Component
3.4. Snippet by Mode of Operation
3.5. Snippet by End-User
3.6. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Technological Advancements in Automated Compounding Devices
4.1.1.2. The Prevalence of Cancer
4.2. Restraints
4.2.1. The High Cost of ACD Systems
4.2.2. Opportunity
4.2.3. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 ANALYSIS
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY PRODUCT TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Intravenous (IV) Compounding Systems *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Oral Liquid Compounding Systems
7.4. TPN (Total Parenteral Nutrition) Compounding Systems
7.5. Chemotherapy Compounding Systems
8. BY TECHNOLOGY
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.1.2. Market Attractiveness Index, By Technology
8.2. Gravimetric Automated Compounding Devices *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Volumetric Automated Compounding Devices
8.4. Syringe-based Automated Compounding Devices
9. BY COMPONENT
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.1.2. Market Attractiveness Index, By Component
9.2. Hardware *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Software
9.4. Services
10. BY MODE OF OPERATION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Operation
10.1.2. Market Attractiveness Index, By Mode of Operation
10.2. Fully Automated Compounding Devices*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Semi-Automated Compounding Devices
11. BY END-USER
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.1.2. Market Attractiveness Index, By End-User
11.2. Hospitals*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Ambulatory Surgical Centers
11.4. Others
12. BY COUNTRY
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.1.2. Market Attractiveness Index, By Country
12.2. North America
12.2.1. U.S.
12.2.2. Canada
12.2.3. Mexico
13. COMPETITIVE LANDSCAPE
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. COMPANY PROFILES
14.1. Grifols, S.A *
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Baxter International Inc
14.3. COMECER S.p.A.
14.4. ARxIUM
14.5. ICU Medical, Inc
14.6. Omnicell, Inc
14.7. EQUASHIELD
14.8. B. Braun Medical Inc
14.9. BECTON, DICKINSON AND COMPANY
14.10. SMARTCOMPOUNDERS B.V. (*LIST NOT EXHAUSTIVE)
15. APPENDIX
15.1. About Us and Services
15.2. Contact Us
